We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

How Broken-Down Brain Recycling Leads to Parkinson's Disease

A plastic brain model backlit in red and green.
Credit: Natasha Connell/ Unsplash
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

Researchers from the University of Queensland have identified that a gene associated with an increased risk of Parkinson’s Disease also contributes to a build-up of cell debris in the brain.


Dr Adekunle Bademosi from The Queensland Brain Institute said the discovery could change the focus of Parkinson’s Disease treatment.

A Parkinson's-linked mutation

“Our team has found that a Parkinson’s Disease-linked mutation in a gene called Endophilin A1 blocks the process by which the body and the brain recycle cell waste,” Dr Bademosi said.


Without the process, called autophagy, toxic debris builds up and neurons die – known hallmarks of Parkinson’s Disease.

Want more breaking news?

Subscribe to Technology Networks’ daily newsletter, delivering breaking science news straight to your inbox every day.

Subscribe for FREE

“We knew we could induce autophagy in cells by starving them of amino acids and the subsequent breakdown of debris tells a protein called EndoA to approach the cell membrane and begin the recycling process,” Dr Bademosi said.


“Now we’ve also seen that regular signals between neurons in the brain starts EndoA-induced autophagy when the electric impulses trigger the release of proteins or neurotransmitters at synapses.

Autophagy breaks down

“Unfortunately, when the Endophilin A1 gene is affected in Parkinson’s, the protein EndoA becomes insensitive to this trigger at the synapse and the debris that should be thrown out for recycling builds up instead.”


Current Parkinson’s treatments tend to focus on clearing out the build-ups and replacing what is lost when too many neurons die.

Potential for new Parkinson's drugs

“It may be time to shift the treatment focus to autophagy as the mechanism underlying these disease hallmarks,” Dr Bademosi said.


“Exploring the use of compounds that induce or inhibit autophagy could pave the way for new, more effective Parkinson’s drugs.”


Reference: Bademosi AT, Decet M, Kuenen S, et al. EndophilinA-dependent coupling between activity-induced calcium influx and synaptic autophagy is disrupted by a Parkinson-risk mutation. Neuron. 2023;0(0). doi: 10.1016/j.neuron.2023.02.001


This article has been republished from the following materials. Note: material may have been edited for length and content. For further information, please contact the cited source.